ArticleDrug design, development and therapy2020

The Activity and Safety of Anlotinib for Patients with Extremity Desmoid Fibromatosis: A Retrospective Study in a Single Institution.

Chuanxi Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.